Swiss National Bank Alkermes Plc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Alkermes Plc. stock. As of the latest transaction made, Swiss National Bank holds 313,800 shares of ALKS stock, worth $9.25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

313,800

Previous 316,200 0.76%

Holding current value

$9.25 Million

Previous $7.62 Million 15.26%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$23.01 - $28.55 $55,224 - $68,520	-2,400 Reduced 0.76%	313,800 $8.78 Million
Q2 2024 Aug 08, 2024	BUY	$23.21 - $27.24 $102,124 - $119,856	4,400 Added 1.41%	316,200 $7.62 Million
Q4 2023 Feb 06, 2024	SELL	$23.37 - $28.68 $394,953 - $484,692	-16,900 Reduced 5.14%	311,800 $8.65 Million
Q3 2023 Nov 08, 2023	BUY	$27.17 - $31.97 $179,322 - $211,002	6,600 Added 2.05%	328,700 $9.21 Million
Q2 2023 Aug 09, 2023	SELL	$28.34 - $33.63 $923,884 - $1.1 Million	-32,600 Reduced 9.19%	322,100 $10.1 Million
Q1 2023 May 10, 2023	SELL	$25.31 - $29.02 $1.06 Million - $1.22 Million	-41,900 Reduced 10.56%	354,700 $10 Million
Q4 2022 Feb 08, 2023	BUY	$21.94 - $26.24 $199,654 - $238,784	9,100 Added 2.35%	396,600 $10.4 Million
Q3 2022 Nov 09, 2022	BUY	$22.0 - $31.87 $112,200 - $162,537	5,100 Added 1.33%	387,500 $8.65 Million
Q1 2022 May 09, 2022	BUY	$23.07 - $27.99 $643,653 - $780,921	27,900 Added 7.87%	382,400 $10.1 Million
Q3 2021 Nov 08, 2021	BUY	$23.37 - $32.13 $81,795 - $112,455	3,500 Added 1.0%	354,500 $10.9 Million
Q2 2021 Aug 06, 2021	SELL	$18.78 - $25.15 $238,506 - $319,405	-12,700 Reduced 3.49%	351,000 $8.61 Million
Q1 2021 May 07, 2021	BUY	$18.21 - $23.2 $71,019 - $90,480	3,900 Added 1.08%	363,700 $6.79 Million
Q3 2020 Nov 09, 2020	BUY	$16.16 - $20.66 $121,200 - $154,950	7,500 Added 2.13%	359,800 $5.96 Million
Q2 2020 Aug 05, 2020	BUY	$13.31 - $19.41 $622,908 - $908,388	46,800 Added 15.32%	352,300 $6.84 Million
Q1 2020 May 08, 2020	BUY	$13.06 - $21.24 $46,402 - $75,465	3,553 Added 1.18%	305,500 $4.41 Million
Q4 2019 Feb 06, 2020	SELL	$17.29 - $21.74 $3.74 Million - $4.7 Million	-216,200 Reduced 41.73%	301,947 $6.16 Million
Q3 2019 Nov 12, 2019	BUY	$19.51 - $24.28 $184,310 - $229,373	9,447 Added 1.86%	518,147 $10.1 Million
Q2 2019 Aug 02, 2019	SELL	$21.47 - $37.33 $203,965 - $354,635	-9,500 Reduced 1.83%	508,700 $11.5 Million
Q1 2019 May 10, 2019	BUY	$28.4 - $36.49 $380,560 - $488,966	13,400 Added 2.65%	518,200 $18.9 Million
Q4 2018 Feb 13, 2019	BUY	$27.94 - $44.61 $332,486 - $530,859	11,900 Added 2.41%	504,800 $14.9 Million
Q3 2018 Nov 08, 2018	SELL	$38.6 - $46.12 $864,640 - $1.03 Million	-22,400 Reduced 4.35%	492,900 $20.9 Million
Q2 2018 Aug 09, 2018	BUY	$40.56 - $51.36 $977,496 - $1.24 Million	24,100 Added 4.91%	515,300 $21.2 Million
Q1 2018 May 04, 2018	SELL	$53.61 - $67.26 $3.89 Million - $4.88 Million	-72,600 Reduced 12.88%	491,200 $28.5 Million
Q3 2017 Nov 03, 2017	BUY	$49.16 - $54.45 $27.7 Million - $30.7 Million	563,800	563,800 $28.7 Million

Others Institutions Holding ALKS

# of Institutions

361

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.84B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Alkermes Plc. Transaction History